You are here: Industry Insights > vaccine

News List

Computer-designed vaccine elicits potent antibodies against RSV worldpharmanews
March 11, 2019
A first-of-its-kind nanoparticle vaccine candidate for respiratory syncytial virus (RSV) has been designed in an international research effort.
Children’s vaccine 87% effective against circulating flu strain firstwordpharma
February 24, 2019
Public Health England (PHE) has published mid-season data on the effectiveness of this year’s flu vaccines, alongside data from other countries, in?Eurosurveillance. The data suggest that the nasal spray flu vaccine is 87% effective in children aged 2 to
United Neuroscience inches closer to Alzheimer’s vaccine prize pharmaphorum
January 22, 2019
A vaccine for Alzheimer’s disease developed by United Neuroscience has cleared a phase IIa trial, and seems to be free of the toxicity that has scuppered earlier candidates.
MinervaX Announces Award of 4.4 Million Euro in Investment from Novo Holdings REPAIR Impact Fund and Sunstone Capital for Further Clinical Development of the Company’s Vaccine Against Group B Streptococcus (GBS) b3cnewswire
January 22, 2019
MinervaX, a privately held Danish biotech company, announces today that is has been awarded an investment of 3.6 mEUR from the Novo Holdings REPAIR Impact Fund for development of therapies to ....
Vaccine, Screening Can Prevent Cervical Cancer Deaths drugs
January 16, 2019
About 4,000 women in the United States die from?cervical cancer?each year -- even though there's a preventive vaccine and screening to catch the disease early....
Danish malaria vaccine passes test in humans worldpharmanews
January 14, 2019
For many years, a team of researchers at the University of Copenhagen have been focussing on developing a vaccine that can protect against the disease pregnancy malaria from which 220,000 people die every year.
Univercells Introduces Vaccine Manufacturing Platform americanpharmaceuticalreview
January 14, 2019
Univercells announced the commercial launch of its proprietary NevoLine bioproduction system for vaccines. The system was initially developed as part of a $12 million Grand Challenges grant awarded by .....
Years into troubled launch, vaccine head says Sanofi's learned some Dengvaxia lessons fiercepharma
January 09, 2019
It's no secret that Sanofi has had a rough time marketing its world-first dengue vaccine, and at the J.P. Morgan Healthcare Conference, vaccine head David Loew told FiercePharma the company gleaned some lessons from the troubled launch.
The Strictest Law for Vaccine: China to Separately Legislate for Vaccine Supervision PharmaSources/Changlin
January 02, 2019
China to separately legislate for vaccine supervision: the law has been submitted to the NPC for deliberation for the first time on Dec. 23, which will be the strictest Law for the vaccine industry in the country.
FDA Approves VAXELIS americanpharmaceuticalreview
December 29, 2018
The U.S. Food and Drug Administration (FDA) has approved VAXELIS (Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed.....